@biodavid.bsky.social
Asha Therapeutics announced some progress in their SARM1 program for ALS. www.businesswire.com/news/home/20...
Asha Therapeutics Awarded Barnett Drug Development Grant by the ALS Association to Advance Novel Intra-Molecular Glue Inhibitor of SARM1 to Clinic and Announces Appointment of Disarm Therapeutics’ Fou...
Asha Therapeutics Selected as Recipient of ALS Association's Barnett Grant, Disarm Therapeutics’ founders Drs. Milbrandt & DiAntonio to join Asha SAB
https://www.businesswire.com/news/home/20241113152837/en/Asha-Therapeutics-Awarded-Barnett-Drug-Development-Grant-by-the-ALS-Association-to-Advance-Novel-Intra-Molecular-Glue-Inhibitor-of-SARM1-to-Clinic-and-Announces-Appointment-of-Disarm-Therapeutics’-Founders-to-Company’s-Scientific-Advisory-Board
November 13, 2024 at 4:41 PM
Asha Therapeutics announced some progress in their SARM1 program for ALS. www.businesswire.com/news/home/20...